The following Structured Product Label (SPL) was submitted to the FDA by Guhada Co., Ltd. for the product Clerivy Microdart Acne (NDC 87934-111). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - when using, otc - active ingredient, keep out of reach of children., dosage & administration, otc - purpose, storage and handling, inactive ingredient, warnings, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
▪ Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
▪ Skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time.
▪ If dryness or peeling develops, decrease use to once daily or every other day.
▪ If irritation occurs, use only one topical acne medication at a time unless directed by a doctor.
▪ Stop use and ask a doctor if Irritation becomes severe.
Salicylic Acid 2%
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
▪ Swipe target area with the included Blemish Clearing Pad.
▪ Once dry, apply the Microdart Acne Patch directly onto the blemish. Press firmly for 10 seconds.
▪ Leave on for 2+ hrs for the microdarts to dissolve (for best results, leave on overnight).
Acne Treatment
Store between 34°F–86°F (1°C–30°C).
Sodium Hyaluronate, Niacinamide, Tranexamic Acid, Sodium Ascorbyl Phosphate, Succinic Acid, Panthenol, Madecassoside, Zinc PCA, Centella Asiatica Extract, Tocopheryl Acetate, Allantoin, 1,2-Hexanediol, Phytosphingosine HCl
For external use only. Do not use on broken or irritated skin.
▪ For the treatment of acne.
▪ Penetrates pores to eliminate most acne blemishes.
Package label Principal Display
* Please review the disclaimer below.
